We have recently made a third-party allotment of shares to several operating companies, including Ryoko Co., Ltd.
We are currently promoting the nationwide expansion of “N-NOSE at home *”, which completes the process of applying for tests, submitting samples, and receiving results while at home. With this capital increase, we will build a stronger testing system and build a stronger testing system. We will strive to improve the value of our services.
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20
HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. －Pre-order available, special discounts ar . . .2023.03.10
Our CEO made a courtesy call on Minister Yasutoshi Nishimura.2023.02.27